Sigilon Therapeutics Correlations
| SGTXDelisted Stock | USD 21.11 0.33 1.54% |
The current 90-days correlation between Sigilon Therapeutics and Reviva Pharmaceuticals Holdings is -0.16 (i.e., Good diversification). The correlation of Sigilon Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Sigilon Therapeutics Correlation With Market
Average diversification
The correlation between Sigilon Therapeutics and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sigilon Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Sigilon |
Moving together with Sigilon Stock
| 0.8 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.69 | WMT | Walmart Aggressive Push | PairCorr |
| 0.66 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
Moving against Sigilon Stock
| 0.86 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.75 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.74 | KO | Coca Cola Sell-off Trend | PairCorr |
| 0.73 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.7 | PBCRY | Bank Central Asia | PairCorr |
| 0.64 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.64 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.55 | PTAIY | Astra International Tbk | PairCorr |
| 0.5 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.48 | PBCRF | PT Bank Central | PairCorr |
| 0.33 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Sigilon Stock performing well and Sigilon Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sigilon Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| RVPH | 4.81 | 0.57 | 0.05 | (0.37) | 5.91 | 10.71 | 40.06 | |||
| ZVSA | 4.10 | (1.47) | 0.00 | (0.36) | 0.00 | 7.57 | 78.93 | |||
| KRBP | 6.00 | 0.08 | 0.00 | 0.08 | 0.00 | 12.04 | 65.24 | |||
| UNCY | 4.28 | 0.93 | 0.17 | 0.69 | 4.33 | 10.26 | 29.22 | |||
| ONCR | 8.13 | (2.39) | 0.00 | (0.97) | 0.00 | 10.00 | 120.67 | |||
| EFTR | 7.57 | (4.57) | 0.00 | (470.75) | 0.00 | 8.70 | 88.91 | |||
| APLM | 6.44 | 0.17 | 0.00 | 0.03 | 0.00 | 8.40 | 134.75 | |||
| ANGN | 5.04 | 0.71 | 0.13 | 0.61 | 5.44 | 11.55 | 42.18 | |||
| CDIO | 6.36 | (0.56) | (0.01) | 0.00 | 6.78 | 14.81 | 57.04 | |||
| SONN | 4.77 | (0.98) | 0.00 | 1.80 | 0.00 | 12.31 | 37.58 |
View Sigilon Therapeutics Related Equities
| Risk & Return | Correlation |
Sigilon Therapeutics Corporate Management
| Philip AshtonRickardt | Chief Officer | Profile | |
| MD MBA | Ex Officer | Profile | |
| Arturo Vegas | CoFounder | Profile | |
| Omid Veiseh | CoFounder | Profile | |
| Daniel Anderson | CoFounder Board | Profile | |
| MBA MD | CEO Pres | Profile |
Still Interested in Sigilon Therapeutics?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.